Showing results (1-10 of 536) with videos related to
Sort By:
Pageof 54
Annals of Hematology|April 11, 2025
Alemtuzumab for haematological malignanciesNing An, Kangqi Bian, Chunrui LiAnnals of Hematology|February 18, 2026
Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case reportXinran Wang, Jia Gu, Ning An, et al.Journal of Cancer|May 6, 2024
CS1 Expression Pattern in NK Cells and Correlated Factors in Plasma Cell dyscrasias: Implications for Elotuzumab Therapy and CAR-T EfficacyChunhui Li, Di Wang, Yanjie Xu, et al.Molecular Medicine Reports|March 18, 2016
S-Adenosylmethionine suppresses the expression of Smad3/4 in activated human hepatic stellate cells via Rac1 promoter methylationKangqi Bian, Feng Zhang, Tingting Wang, et al.Thrombosis Research|May 26, 2023
Recovery-model: A model for CAR T-cell-related thrombocytopenia in relapsed/refractory multiple myelomaZhe Li, Yimei Que, Di Wang, et al.Frontiers in Genetics|July 2, 2025
Transcriptomic analysis and machine learning modeling identifies novel biomarkers and genetic characteristics of hypertrophic cardiomyopathyFeng Zhang, Chunrui Li, Lulu ZhangMedicine|October 30, 2015
Oral Contraceptives Use and Liver Cancer Risk: A Dose-Response Meta-Analysis of Observational StudiesNing AnJournal of Cellular and Molecular Medicine|May 22, 2025
Harnessing Cellular Immunotherapy for EBV-Associated Malignancies: Current Advances and Future DirectionsYang Gao, Di Wang, Chunrui LiFrontiers in Medicine|May 17, 2024
Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapyXiaolu Long, Ning An, Chunhui Li, et al.Journal of Translational Medicine|May 16, 2025
Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myelomaNing An, Juan Li, Pan Luo, et al.Pageof 54